Elvanse 40 mg hard caps. Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

elvanse 40 mg hard caps.

takeda pharmaceuticals international ireland branch ag - lisdexamfetamine dimesylate 40 mg - eq. dexamfetamine 11,9 mg - capsule, hard - 40 mg - lisdexamfetamine dimesylate 40 mg - lisdexamfetamine

Elvanse 50 mg hard caps. Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

elvanse 50 mg hard caps.

takeda pharmaceuticals international ireland branch ag - lisdexamfetamine dimesylate 50 mg - eq. dexamfetamine 14,8 mg - capsule, hard - 50 mg - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine

Elvanse 60 mg hard caps. Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

elvanse 60 mg hard caps.

takeda pharmaceuticals international ireland branch ag - lisdexamfetamine dimesylate 60 mg - eq. dexamfetamine 17,8 mg - capsule, hard - 60 mg - lisdexamfetamine dimesylate 60 mg - lisdexamfetamine

Elvanse 70 mg hard caps. Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

elvanse 70 mg hard caps.

takeda pharmaceuticals international ireland branch ag - lisdexamfetamine dimesylate 70 mg - eq. dexamfetamine 20,8 mg - capsule, hard - 70 mg - lisdexamfetamine dimesylate 70 mg - lisdexamfetamine

LISDEX TEVA 30 MG Israel - engelsk - Ministry of Health

lisdex teva 30 mg

teva israel ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 30 mg - lisdexamfetamine - lisdex teva is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above. lisdex teva is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years. limitation of use: lisdex teva is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of lisdex teva for the treatment of obesity have not been established.

LISDEX TEVA 40 MG Israel - engelsk - Ministry of Health

lisdex teva 40 mg

teva israel ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 40 mg - lisdexamfetamine - lisdex teva is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above. lisdex teva is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years. limitation of use: lisdex teva is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of lisdex teva for the treatment of obesity have not been established.